RaQualia Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	26,092	8,386	14,874	25,843	24,601	20,952
Market Cap Growth	207.94%	-43.62%	-42.44%	5.05%	17.42%	-25.38%
Enterprise Value	25,599	8,784	11,061	22,330	21,890	18,543
Last Close Price	1003.00	384.00	688.00	1232.00	1174.00	1000.00
PE Ratio	-	-	-	35.74	32.58	-
Forward PE	-	14.31	19.50	74.48	78.27	91.95
PS Ratio	8.56	2.70	7.83	8.86	8.86	18.93
PB Ratio	4.32	1.51	2.43	4.70	5.14	5.23
P/TBV Ratio	11.30	5.03	2.44	4.72	5.18	5.27
P/FCF Ratio	-	99.83	-	17.84	89.79	-
P/OCF Ratio	-	46.59	-	17.46	67.22	-
EV/Sales Ratio	8.40	2.83	5.82	7.65	7.89	16.75
EV/EBITDA Ratio	-	46.72	-	22.02	25.78	-
EV/EBIT Ratio	-	-	-	25.76	30.92	-
EV/FCF Ratio	-90.14	104.57	-	15.41	79.89	-
Debt / Equity Ratio	0.51	0.62	0.06	0.04	0.01	0.01
Debt / EBITDA Ratio	-	18.35	-	0.22	0.04	-
Debt / FCF Ratio	-	41.07	-	0.15	0.14	-
Asset Turnover	0.32	0.38	0.29	0.51	0.59	0.24
Inventory Turnover	4.31	3.98	3.16	25.67	40.13	25.09
Quick Ratio	4.11	3.40	11.22	9.18	9.66	14.21
Current Ratio	4.66	3.82	12.74	9.78	10.01	15.24
Return on Equity (ROE)	-12.40%	-8.47%	-5.56%	14.06%	17.17%	-14.05%
Return on Assets (ROA)	-3.44%	-1.61%	-3.21%	9.43%	9.33%	-6.69%
Return on Invested Capital (ROIC)	-9.31%	-5.07%	-14.93%	37.26%	29.61%	-22.29%
Return on Capital Employed (ROCE)	-6.20%	-2.50%	-5.20%	15.00%	14.60%	-12.00%
Earnings Yield	-2.78%	-5.90%	-2.17%	2.80%	3.07%	-2.89%
FCF Yield	-1.09%	1.00%	-6.21%	5.61%	1.11%	-2.09%
Buyback Yield / Dilution	-6.29%	-0.16%	-2.97%	-0.05%	-0.10%	-1.62%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.